Mr. Stanley leads the development of innovative botanical drugs aimed at treating conditions like autism and depression. As the founding CEO of Charlotte’s Web, Joel played a pivotal role in transforming the company from its inception in 2012 to a successful IPO in 2018, achieving over $75 million in annual revenue. His tenure at Charlotte’s Web fueled his passion for botanical healing, paving the way for his current venture at Ajna Biosciences. Under his leadership, Ajna has raised significant funds to advance its drug development efforts.